Reasonable Attempt at a Randomized Trial in Relapsed Rhabdomyosarcoma

Affiliations

Editorial

Abha A Gupta. J Clin Oncol. 2021.

. 2021 Sep 20;39(27):2977-2978.

doi: 10.1200/JCO.21.01631. Epub 2021 Aug 12.

¹ Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.

No abstract available

Comment on

Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial.
Defachelles AS, Bogart E, Casanova M, Merks JHM, Bisogno G, Calareso G, Gallego Melcon S, Gatz SA, Le Deley MC, McHugh K, Probst A, Rocourt N, van Rijn RR, Wheatley K, Minard-Colin V, Chisholm JC. Defachelles AS, et al. J Clin Oncol. 2021 Sep 20;39(27):2979-2990. doi: 10.1200/JCO.21.00124. Epub 2021 Aug 3. J Clin Oncol. 2021. PMID: 34343032 Clinical Trial.